16157899

Source:http://linkedlifedata.com/resource/pubmed/id/16157899

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0025914, umls-concept:C0026336, umls-concept:C0026339, umls-concept:C0026809, umls-concept:C0027756, umls-concept:C0030705, umls-concept:C0033414, umls-concept:C0270911, umls-concept:C0445254, umls-concept:C1413535, umls-concept:C2698698
pubmed:issue	5
pubmed:dateCreated	2005-9-13
pubmed:abstractText	Xenografts from patients with Charcot-Marie-Tooth type 1A (CMT1A) have shown delayed myelination and impaired regeneration of nude mice axons passing through the grafted segments. Neurotrophin-3 (NT-3), an important component of the Schwann cell (SC) autocrine survival loop, could correct these deficiencies.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/M01-RR00034
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16157899-16157894
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Myelin Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neurotrophin 3, http://linkedlifedata.com/resource/pubmed/chemical/PMP22 protein, human
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1526-632X
pubmed:author	pubmed-author:CedarbaumJ MJM, pubmed-author:FreimerM LML, pubmed-author:KingW MWM, pubmed-author:McCrackenB SBS, pubmed-author:MendellJ RJR, pubmed-author:NagarajaH NHN, pubmed-author:SahenkZZ
pubmed:issnType	Electronic
pubmed:day	13
pubmed:volume	65
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	681-9
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16157899-Adolescent, pubmed-meshheading:16157899-Adult, pubmed-meshheading:16157899-Animals, pubmed-meshheading:16157899-Charcot-Marie-Tooth Disease, pubmed-meshheading:16157899-Disease Models, Animal, pubmed-meshheading:16157899-Double-Blind Method, pubmed-meshheading:16157899-Female, pubmed-meshheading:16157899-Humans, pubmed-meshheading:16157899-Male, pubmed-meshheading:16157899-Mice, pubmed-meshheading:16157899-Mice, Neurologic Mutants, pubmed-meshheading:16157899-Mice, Nude, pubmed-meshheading:16157899-Mice, Transgenic, pubmed-meshheading:16157899-Middle Aged, pubmed-meshheading:16157899-Myelin Proteins, pubmed-meshheading:16157899-Nerve Regeneration, pubmed-meshheading:16157899-Neurotrophin 3, pubmed-meshheading:16157899-Pilot Projects, pubmed-meshheading:16157899-Recovery of Function, pubmed-meshheading:16157899-Sciatic Neuropathy, pubmed-meshheading:16157899-Sural Nerve, pubmed-meshheading:16157899-Transplantation, Heterologous, pubmed-meshheading:16157899-Treatment Outcome
pubmed:year	2005
pubmed:articleTitle	NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients.
pubmed:affiliation	Department of Neurology, Ohio State University, Columbus, OH, USA. Sahenk.1@osu.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, N.I.H., Extramural